• Policy
• Promote disclosure of anticancer drug Expedite Review result
• by Kim, Jung-Ju Mar 9, 2021 06:24am

• Company
• First CAR-T treatment Kymriah was approved in Korea
• by Eo, Yun-Ho Mar 9, 2021 06:24am

• Policy
• Soliris follow-on Ultomiris conditionally listed
• by Lee, Hye-Kyung Mar 9, 2021 06:24am

• Company
• Antihypertension Zofenil and Adalat Oros to halt supply
• by Mar 9, 2021 06:24am

• Company
• Mercilon's sales fell 16%
• by Kim, Jin-Gu Mar 8, 2021 06:20am

• Opinion
• [Reporter’s Eye] Needs transparency in Cancer Committee
• by Eo, Yun-Ho Mar 8, 2021 06:20am

• Policy
• GC Pharma-Moderna-KCDC ink COVID-19 vaccine contract
• by Lee, Jeong-Hwan Mar 8, 2021 06:20am

• Company
• Pantogar's Sales cut in half
• by Mar 8, 2021 06:19am

• Policy
• Amivantamab designated as a rare drug
• by Lee, Tak-Sun Mar 8, 2021 06:19am

• Company
• Hepatitis C treatment Vosevi was refocused
• by Eo, Yun-Ho Mar 5, 2021 06:26am